Alaunos Therapeutics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Alaunos Therapeutics Inc.
Alaunos Therapeutics Inc is a preclinical stage obesity and metabolic health drug development company that is aiming to develop a small molecule-based drug to treat obesity and other metabolic disorders that have a differentiated profile relative to currently marketed and in development oral and injectable products. The company focuses on evaluating the impact of ALN1001, its primary program, and its derivatives on lipid deposition and gene expression. It aims to develop an oral obesity compound that addresses many of the shortcomings of injectable GLP-1 receptor agonists including preserving lean muscle mass.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Alaunos Therapeutics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Alaunos Therapeutics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Alaunos Therapeutics Inc. is TCRT:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Alaunos Therapeutics Inc. has its primary listing on NASDAQ (Small cap). You can trade Alaunos Therapeutics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Alaunos Therapeutics Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Alaunos Therapeutics Inc. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Alaunos Therapeutics Inc..